Different bile concentration of micafungin and itraconazole in a patient with candidal cholecystitis

Journal of Infection

Volumn 58, Issue 4, 2009, Pages 315-316

  Maruyama, Takaya ^a   Takei, Yoshiyuki ^a   Gabazza, Esteban C ^a   Morser, John ^a   Taguchi, Osamu ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ITRACONAZOLE; MICAFUNGIN;

ABSENCE OF SIDE EFFECTS; AGED; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA CHOLECYSTITIS; CASE REPORT; CHOLECYSTITIS; DRUG BILE LEVEL; DRUG EFFICACY; ESOPHAGUS CANCER; FUNGAL EYE INFECTION; FUNGUS ISOLATION; HUMAN; INFECTIOUS COMPLICATION; INVASIVE CANDIDIASIS; LABORATORY TEST; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERCUTANEOUS DRAINAGE; PERCUTANEOUS TRANSHEPATIC DRAINAGE; PHYSICAL EXAMINATION; RETINOPATHY;

AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BILE; CANDIDIASIS; CHOLECYSTITIS; ECHINOCANDINS; ESOPHAGEAL NEOPLASMS; HUMANS; ITRACONAZOLE; LIPOPEPTIDES; MALE;

EID: 63149157955     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.02.004     Document Type: Letter

References (9)

1. Marsh P.K., Tally F.P., Kellum J., Callow A., and Gorbach S.L. Candida infections in surgical patients. Ann Surg 198 (1983) 42-47
2. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., et al. Guidelines for treatment of candidasis. Clin Infect Dis 38 (2004) 161-189
3. Diebel L.N., Raafat A.M., Dulchavsky S.A., and Brown W.J. Gallbladder and biliary tract candidiasis. Surgery 120 (1996) 760-764
4. Kulaksiz H., Rudolph G., Kloeters-Plachky P., Sauer P., Geiss H., and Stiehl A. Biliary candida infections in primary sclerosing cholangitis. J Hepatol 45 5 (2006) 711-716
5. Goicoechea M., Fierer J., and Johns S. Treatment of candidal cholangitis with caspofungin therapy in a patient with a liver transplant: documentation of biliary excretion of caspofungin. Clin Infect Dis 38 (2004) 1040-1041
6. Brooks Jr. B.J., Williams W.L., Sanders C.V., and Marier R.L. Apparent ketoconazole failure in candidal cholecystitis. Arch Intern Med 142 (1982) 1934-1935
7. Abe F., Ueyama J., Kimata A., Kato M., Hayashi T., Nadai M., et al. Involvement of multidrug resistance-associated protein 2 (ABCC/2Mrp2) in biliary excretion of micafungin in rats. Life Sci 83 (2008) 229-235
8. Shin J.H., Choi K.Y., Kim Y.C., and Lee M.G. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect. Antimicrobial Agents Chemother 48 (2004) 1756-1762
9. Sandhu P., Xu X., Bondiskey P.J., Balani S.K., Morris M.L., Tang Y.S., et al. Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys. Antimicrobial Agents Chemother 48 (2004) 1272-1280